Page last updated: 2024-12-05
2,6-diethylaniline
Description
2,6-Diethylaniline is an organic compound with the formula C10H15N. It is a colorless liquid that is used as an intermediate in the synthesis of dyes, pharmaceuticals, and other organic compounds. The compound is typically synthesized via the reduction of 2,6-dinitroethylbenzene using either catalytic hydrogenation or iron in acidic conditions. 2,6-Diethylaniline is an important intermediate in the synthesis of several drugs including antimalarials, antiseptics, and local anesthetics. The compound is also studied for its potential application in the synthesis of novel organic materials, such as conducting polymers.'
2,6-diethylaniline: one of the major metabolites of the herbicide alachlor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 11369 |
CHEMBL ID | 3184218 |
SCHEMBL ID | 262868 |
MeSH ID | M0227362 |
Synonyms (58)
Synonym |
4-12-00-02841 (beilstein handbook reference) |
vt2234594h , |
unii-vt2234594h |
2,6-diethyl aniline |
benzamine, 2,6-diethyl- |
ai3-26297 |
brn 1423626 |
hsdb 5699 |
einecs 209-445-7 |
ccris 2688 |
2,6-diethylbenzenamine |
benzenamine, 2,6-diethyl- |
aniline, 2,6-diethyl- |
2,6-diethylaniline |
579-66-8 |
inchi=1/c10h15n/c1-3-8-6-5-7-9(4-2)10(8)11/h5-7h,3-4,11h2,1-2h |
2,6-diethylaniline, 98% |
D0476 |
diethylaminobenzene |
2-amino-1,3-diethylbenzene |
2,6 diethylaniline |
AKOS000120339 |
A831688 |
NCGC00247995-02 |
NCGC00247995-01 |
(2,6-diethyl-phenyl)-amine |
2,6-diethyl-aniline |
dtxsid6027218 , |
tox21_202010 |
dtxcid607218 |
NCGC00259559-01 |
cas-579-66-8 |
tox21_300333 |
NCGC00254454-01 |
2,6-diethylphenylamine |
FT-0610638 |
2,6-diethylaniline [hsdb] |
SCHEMBL262868 |
2.6-diethylaniline |
4-iodopyridine-2,6-dicarboxylicacid |
W-105426 |
CHEMBL3184218 |
mfcd00007753 |
AC-10108 |
2,6-diethylaniline, >=99.5% |
2,6-diethylaniline, pestanal(r), analytical standard |
2,6-diethyl-benzenamine |
2,6-diethyl-benzamine |
2,6-diethylbenzenamine, 9ci |
CS-W018171 |
F0001-1508 |
STL570693 |
DS-13621 |
Q209276 |
AM10640 |
D77824 |
EN300-20612 |
Z104479240 |
Research Excerpts
Dosage Studied
Protein Targets (2)
Potency Measurements
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (45.45) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 33.19
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 33.19 (24.57) | Research Supply Index | 2.56 (2.92) | Research Growth Index | 4.44 (4.65) | Search Engine Demand Index | 37.47 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |